Literature DB >> 15504399

Anti-termination by SIV Tat requires flexibility of the nascent TAR structure.

Peter Sommer1, Jean-Pierre Vartanian, Malte Wachsmuth, Michel Henry, Denise Guetard, Simon Wain-Hobson.   

Abstract

Substitution of the SIVmac239 promoter/enhancer by the strong EF1alpha promoter results in a severe replication defect due to a failure to respond to Tat. Revertant viruses with minimal promoter sequences (two Sp1 sites and a TATA box) were obtained that had fully restored their replicative potential. Comparison of the different LTRs indicated that structural alterations in the TAR stem due to a 31bp exon of the EF1alpha promoter rather than the mere presence of transcription factor binding sites within U3 were responsible for the attenuation. Structural models based on genuine RNA sequences combined with a refined algorithm to calculate the probability of the looping-mediated interaction between protein complexes bound to nucleic acid polymers indicated that the local concentration of TAR-bound Tat close to the RNA polymerase II complex was reduced more than 100-fold for the mutant as compared to SIVmac239. These results show that HIV/SIV replication requires only a minimal set of cis-acting elements in the promoter and suggest a hitherto unrecognised requirement of flexibility for the nascent TAR structure to allow anti-termination by Tat.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15504399     DOI: 10.1016/j.jmb.2004.09.042

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  4 in total

1.  Identification of two HIV inhibitors that also inhibit human RNaseH2.

Authors:  Junghwan Kim; Jaewan Yoon; MoonKyeong Ju; Yunmi Lee; Tae-Hee Kim; Junwon Kim; Peter Sommer; Zaesung No; Jonathan Cechetto; Sung-Jun Han
Journal:  Mol Cells       Date:  2013-09-02       Impact factor: 5.034

2.  HIV-1 clade promoters strongly influence spatial and temporal dynamics of viral replication in vivo.

Authors:  Mireille Centlivre; Peter Sommer; Marie Michel; Raphaël Ho Tsong Fang; Sandrine Gofflo; Jenny Valladeau; Nathalie Schmitt; Françoise Thierry; Bruno Hurtrel; Simon Wain-Hobson; Monica Sala
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

3.  Epithelial stem cells as mucosal antigen-delivering cells: A novel AIDS vaccine approach.

Authors:  Robert White; Nicole Chenciner; Gregory Bonello; Mary Salas; Philippe Blancou; Marie-Claire Gauduin
Journal:  Vaccine       Date:  2013-11-25       Impact factor: 3.641

4.  Identification of a novel sulfonamide non-nucleoside reverse transcriptase inhibitor by a phenotypic HIV-1 full replication assay.

Authors:  Tae-Hee Kim; Yoonae Ko; Thierry Christophe; Jonathan Cechetto; Junwon Kim; Kyoung-Ae Kim; Annette S Boese; Jean-Michel Garcia; Denis Fenistein; Moon Kyeong Ju; Junghwan Kim; Sung-Jun Han; Ho Jeong Kwon; Vincent Brondani; Peter Sommer
Journal:  PLoS One       Date:  2013-07-18       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.